In Vitro Diagnostic (IVD) Trends and Market Update, December 2025
Description
Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 delivers critical insights into the evolving IVD market amid global economic uncertainties. Published twice annually—in April and in December following the release of Kalorama’s flagship study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves as both a standalone resource and a strategic companion for decision-makers in the diagnostics industry.
The 2025 IVD market continues its growth trajectory, fueled by technological breakthroughs and rising healthcare demands. Innovations in next-generation sequencing (NGS), microfluidics, and precision medicine are transforming diagnostics, enabling highly accurate, sensitive, and personalized testing for complex conditions such as cancer and genetic disorders. The surge in companion diagnostics and multiplex testing underscores a shift toward patient-centric care and deeper disease insights.
Key growth segments attracting industry attention include Point-of-Care testing, cancer diagnostics, companion diagnostics technologies, immunochemistry, and mass spectrometry. Nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for significant expansion, shaping the future of IVD.
This report provides actionable intelligence on:
The 2025 IVD market continues its growth trajectory, fueled by technological breakthroughs and rising healthcare demands. Innovations in next-generation sequencing (NGS), microfluidics, and precision medicine are transforming diagnostics, enabling highly accurate, sensitive, and personalized testing for complex conditions such as cancer and genetic disorders. The surge in companion diagnostics and multiplex testing underscores a shift toward patient-centric care and deeper disease insights.
Key growth segments attracting industry attention include Point-of-Care testing, cancer diagnostics, companion diagnostics technologies, immunochemistry, and mass spectrometry. Nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for significant expansion, shaping the future of IVD.
This report provides actionable intelligence on:
- Market drivers and major industry trends
- New product developments shaping innovation
- Competitive landscape and key player strategies
- Emerging opportunities and high-growth segments
Table of Contents
52 Pages
- About Kalorama Information
- IVD Market Demand and Growth
- Effect of COVID-19 on Market Segments
- Selected New – Q3 2025 - Core IVD Product Launches, Developments and Trends
- Selected COVID-19 Developments – Q3 2025
- Selected Competitive Leader Updates
- Q3 2025 M&A Activity
- Abbott Laboratories
- Becton Dickinson and Co
- bioMérieux SA
- Danaher Corporation
- Dexcom, Inc
- Exact Sciences
- Roche Diagnostic
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Personalized Medicine
- Genetic Testing in Disease
- Microbiome
- IVD Digital Diagnostics
- Tariffs
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
